Medplus Health Services Q3 FY26 Results: Profit Up, ESOP Allotment
MedPlus Health Services reported Q3 FY26 results with consolidated revenue at ₹18,061 crore and net profit at ₹578 crore. Standalone revenue was ₹2,230 crore with a net profit of ₹166 crore. The company also approved the allotment of 2,32,061 ESOP shares.
The results show growth, but the ESOP allotment is not material. The impact of the new labor codes is being monitored, but no significant financial impact is currently reported.
The company reported an increase in profits and revenue for the quarter, which is a positive financial indicator. The ESOP allotment is a routine event and not material.
MedPlus Health Services Limited announced the outcome of its Board Meeting held on January 30, 2026. The Board approved the un-audited standalone and consolidated financial results for the quarter ended December 31, 2025. The statutory auditors, M/s B S R and Co., provided an unmodified opinion in their limited review report.
Additionally, the Board approved the allotment of 2,32,061 Equity Shares under the MedPlus Employees Stock Option Plan, 2021, to eligible employees. This allotment was deemed not material to the company.
The financial results indicated consolidated revenue from operations of ₹18,061.18 crore (18,061.18 million) and a net profit after tax of ₹577.88 crore (577.88 million) for the quarter ended December 31, 2025. For the nine months ended December 31, 2025, consolidated revenue was ₹50,280.81 crore (50,280.81 million) and net profit after tax was ₹1,556.33 crore (1,556.33 million).
Standalone revenue from operations for the quarter ended December 31, 2025, was ₹2,230.01 crore (2,230.01 million), with a net profit after tax of ₹165.76 crore (165.76 million). For the nine months ended December 31, 2025, standalone revenue was ₹6,125.30 crore (6,125.30 million) and net profit after tax was ₹457.40 crore (457.40 million).
The company also noted the impact of the four Labour Codes notified by the Government of India, with an assessed incremental non-recurring impact of INR 70.59 million recorded as employee benefits expense in the consolidated results.
What to do with a filing like this
Medplus Health Services Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Medplus Health Services Limited. Read the original for the full detail.